Economic Burden of Multiple Sclerosis Drugs in Iran during 2011–2019

BACKGROUND: Due to the invariably progressive nature of multiple sclerosis (MS) and the high economic burden of chronic diseases, this study was performed to estimate the economic burden of MS medications in Iran. METHODS: The present research is a descriptive study performed using comprehensive nat...

Descripción completa

Detalles Bibliográficos
Autores principales: Asadollahi, Mina, Darvishi, Ali, Azimi, Amirreza, Annabi, Majid, Jafariazar, Zahra, Heshmat, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113575/
https://www.ncbi.nlm.nih.gov/pubmed/37089141
http://dx.doi.org/10.18502/ijph.v52i2.11894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113575/
https://www.ncbi.nlm.nih.gov/pubmed/37089141
http://dx.doi.org/10.18502/ijph.v52i2.11894

Ejemplares similares